Dr. Danilo Casimiro is Vice President and Head of Global Research and External Innovation at Sanofi Pasteur.  He is responsible for vaccine research and search-and-evaluation function for external vaccine and vaccine technology opportunities.  He has more than two decades of experience in research and development of vaccines and biologics in both pharmaceutical and non-profit sectors.  Prior to joining Sanofi Pasteur on November 2017, he was the Chief Scientific Officer at Aeras, a non-profit organization dedicated to the development of new and more effective tuberculosis vaccines; he played a leading role in developing the long-term scientific strategy for the field and advancing promising candidates to the development stages. During his 19 years at the Merck Research Laboratories, Dr. Casimiro contributed to the licensure of Merck’s papillomavirus vaccines, and the development of novel vaccine candidates against several viral pathogens including herpesviruses, ebola, HIV-1, RSV, and dengue, and monoclonal antibodies against respiratory pathogens and oncology targets.  As a prominent scientific leader, he has also served on numerous advisory committees to the Bill & Melinda Gates Foundation Global Health Program, International AIDS Vaccine Initiative, NIH Integrated Preclinical/Clinical AIDS Vaccine Development Program, U.S. Agency for International Development, HIV Vaccine Enterprise, and Human Vaccine Project. Dr. Casimiro received his B.S. and Ph.D. degrees in Chemistry from the University of the Philippines and the California Institute of Technology, respectively.